AzTrials
AzTrials

Clinical BurnoutReWorkNCT07079709

Returning to Work After Stress-Related Sick Leave: An Effectiveness Trial of Work-Focused Treatments in Primary Care

A study testing Workfocused CBT in people with Clinical Burnout and Exhaustion Disorder, run by Karolinska Institutet.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if work-focused cognitive behaviour (WCBT) works to treat patients on sick leave due to non-traumatic long-term stress-related disorders. Read more about this study

Who is it for?
Ages 18 to 60 years
What is being tested?
Workfocused CBT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
204 participants
Where
No sites listed yet
Study dates
1 Aug 2025to 1 Dec 2034
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • be on sick leave at least 50%
  • be diagnosed with a primary diagnosis adjustment disorder (F43.2-F.43.9) including exhaustion disorder (F43.8A)
  • be of working age (18-60 years)
  • be able to understand verbal and written Swedish or English
  • give informed consent

Who cannot join

  • other psychiatric conditions that require prioritization for immediate or simultaneous treatment: specifically, a current diagnosis of bipolar disorder, schizophrenia, schizoaffective disorder, or organic mental disorder; current high risk of suicide; or recent (within 3 months) history of substance use disorder)
  • other ongoing or recent (within 6 months) psychological treatment for stress-related disorders

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Anna C Finnes, PhD contact

+46 70 374 08 79

anna.finnes@ki.se

Anastasiya Zakrevska, MS contact

anastasiya.zakrevska@ki.se

About this study

The goal of this clinical trial is to learn if work-focused cognitive behaviour (WCBT) works to treat patients on sick leave due to non-traumatic long-term stress-related disorders. The main questions it aims to answer are:

  • Is WCBT more effective in improving work ability compared to standard care?
  • Do participants in WCBT have less sick leave days than those in standard care?
  • Is WCBT more effective in improving health outcomes and function than standard care?
  • Is WCBT a more cost-effective treatment option than standard care? Researchers will compare WCBT to standad care to see if there are differences in effect.

Participants will participate in:

  • WCBT
  • Standard care
Being tested
Workfocused CBT, Standard Care (in control arm)
Keywords
Work-focused CBT, WCBT, Sick leave, Clinical burnout, Cognitive behaviour therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Workfocused CBTBehavioural

    Also called WCBT

    In WCBT, the central idea is that CBT techniques can be applied in a work context with the aim of achieving both usual treatment goals related to symptoms and RTW. To ensure positive effects at both symptomatic and functional levels, a work perspective must be fully integrated into the intervention to optimize the treatment effect which demands collaboration with the sick leave prescribing doctor and the patient's employer. The protocol is based on principles of increasing return-to-work self-efficacy (RTW-SE). Work-specific components, such as work anamnesis, adjusting the difficulty of work tasks, and developing a return-to-work plan that includes recommendations for workplace accommodations, are integrated into all treatment sessions.

  • Standard Care (in control arm)Other

    Standard Care is defined as care by the sick leave prescribing physician and the rehab coordinator. Other interventions such as psychological treatment, physiotherapy etc. may also be included in this arm.

Study groups in NCT07079709
Study groupRoleWhat they receive
WCBTExperimentalWork-focused Cognitive Behaviour Therapy
Receives: Behavioral: Workfocused CBT
Standard CareActive comparatorStandard Care is defined as care by the sick leave prescribing physician and the rehab coordinator. Other interventions such as psychological treatment, physiotherapy etc. may also be included in this arm.
Receives: Other: Standard Care (in control arm)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Work Ability Index (WAI) including Work Ability Score (WAS)

    Self-reported change in work ability. WAI consists of 7 domains, 11 questions in total. WAS is the first question of WAI.

    Measured: WAI: Baseline, 6 months, 1- and 2 year follow-up. WAS: every two weeks during the first six months.

Secondary outcomes (17)
  1. Sick leave

    Register data MiDAS from the Swedish Social Insurance Agency reflecting sickness absence - start- and stop date, both episodes and monthly panels for sickness benefit and activity compensation, diagnose, employment/occupation and paid out compensation.

    Measured: The time horizon is two years prior to and five years after the date for inclusion in the study.

  2. Current work status and sick leave

    Participants will respond to the questions "Have you worked during the past week?" and "Are you currently on sick leave?". If yes, participants reports the proportion (25, 50, 75 or 100%) related to normal working hours.

    Measured: Baseline, every two weeks until 6 months, 1- and 2-year follow-up.

  3. Shirom-Melamed Burnout Questionnaire (SMBQ-6)

    Six items. Labels have been added to the original response scale. The participant can rate whether they experience the symptom "never", "almost never", "rarely", "sometimes" "fairy often", "almost always", "always".

    Measured: Baseline, every two weeks during 6 months, 1- and 2-year follow-up.

  4. Insomnia Severy Index (ISI)

    7 items.

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  5. Checklist Individual Strength

    This 20-item scale measures symptoms of fatigue. The participant is asked to rate statements and if he/she felt it during the last two weeks. Examples of questions are: "I feel tired", "I think I do a lot in a day", etc. The statements are rated on a 7-point scale with added labels as follows: "never true", "very rarely true", "rarely true", "sometimes true", "quite often true", "very often true", and "always true".

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  6. Patient Health Questionnaire (PHQ-9)

    Measures depressive symptoms. The occurrence of symptoms during the past two weeks is originally rated on a four-point scale labeled "not at all" to "nearly every day". To capture a more accurate estimation, an additional option category was added following a newly published study (see ref below). In addition, the highest option was adjusted from "nearly every day" to "every day" due to a high similarity between two options. The final response scale had the following five categories: "Not at all", "once or twice", "several days", "more than half the days", and "every day". The patient also rated how difficult those symptoms have made it for the participant to handle activities in everyday life.

    Ref: Makowski, D., Te, A., Neves, A., \& Chen, S. A. (2024). Measuring Depression and Anxiety with 4 items? Adaptation of the PHQ-4 to increase its Sensitivity to Subclinical Variability. PsyArXiv. https://doi.org/10.31234/osf.io/436np

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  7. Generalized Anxiety Disorder Assessment (GAD-7)

    7 items. The occurrence of symptoms during the past two weeks is originally rated on a four-point scale labeled "not at all" to "nearly every day". To capture a more accurate estimation, an additional option category was added following a newly published study (see ref below). In addition, the highest option was adjusted from "nearly every day" to "every day" due to a high similarity between two options. The final response scale had the following five categories: "Not at all", "once or twice", "several days", "more than half the days", and "every day".

    Ref: Makowski, D., Te, A., Neves, A., \& Chen, S. A. (2024). Measuring Depression and Anxiety with 4 items? Adaptation of the PHQ-4 to increase its Sensitivity to Subclinical Variability. PsyArXiv. https://doi.org/10.31234/osf.io/436np

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  8. Short Form Survey (SF-12)

    Measures quality of life in eight domains by 12 items.

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  9. Return to work Self-efficacy Scale

    Nine items from the original 11-item questionnaire were chosen, and items 3 and 11 were rewritten in order to achieve consistency in the wording. Item 2 was removed due to the overlap with item 4. Item 6 was removed since the question did not concern self-efficacy. Answers are rated on a 6-point labeled scale from "totally disagree" to "totally agree".

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  10. Work Phobia Questionnaire - short version

    Items 1, 2, 7, 9, 13 from the original questionnaire were chosen. In addition, labels were added to the six-point scale: "strongly disagree", "mostly disagree", "somewhat disagree", "somewhat agree", "mostly agree", "strongly agree".

    Measured: Baseline, every two weeks until 6 months, 1- and 2 year follow-up.

  11. Perceived Competence Scale

    4 items.

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  12. Psychological avoidance of stress - The psychological inflexibility in stress scale

    A subscale concering aviodance from the psychological inflexibility in pain scale was modified to measure aviodance related to stress. The word "pain" from the original scale was replaced by "stress". 8 items.

    Measured: Baseline, every two weeks during 6 months, 1- and 2 year follow-up.

  13. Lifestyle habits

    12 items.

    Measured: Baseline, 6 months, 1- and 2 year follow-up.

  14. Expactancy of improvement/Credibility

    The questions are inspired from the questionnaire "Credibility/Expectancy Questionnaire" but are designed for this study. 3 items: (I) how relevant the treatment seems at the moment, from "not at all" to "completely", (II) prediction of how the treatment will affect symptoms and (III) work ability, from "it will become much worse" to "it will be much better".

    Measured: Only for the experimental group: 4 weeks after inclusion.

  15. Working Alliance Inventory

    6 items.

    Measured: Only for the experimental group: 4 weeks after baseline and 6 months post enrollment.

  16. Client Satisfaction Questionnaire

    8 items.

    Measured: Only for the intervention group: 6 months after enrollment.

  17. Negative Effects Questionnaire - short version

    Five questions are used from the original instrument, the Negative Effects Questionnaire. Included items: (I) the perception of being less competent, (II) worsening of the problem, (III) thoughts that the issue would not get better, (IV) feeling of shame due to having the treatment, (V) and development of dependency towards the therapist. If any of the statesmen were experienced, the participant rates how much it affects him/her on a scale from "not at all" to "extremely" and if it was caused by the treatment or other circumstances.

    Measured: 6 months post enrollment.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2025
  2. Study start1 Aug 2025 (estimated)
  3. Primary completion1 Dec 2030 (estimated)
  4. Study completion1 Dec 2034 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Non-randomized controlled multi-center study, where control group centers providing treatment as usual are matched using the Care Need Index. Estimation of treatment effects will be conducted using either doubly robust inverse probability of treatment weights or targeted maximum likelihood estimation, depending on the outcome.
Masking
None (open label)
Enrolment
204 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07079709
Sponsor's protocol ID
2025-01713-01
Other IDs
2023-01487, 2023, 2025
Acronym
ReWork
Status last verified
Jul 2025
First submitted
14 Jul 2025
Last updated
23 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Workfocused CBT in people with Clinical Burnout and Exhaustion Disorder, run by Karolinska Institutet.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anna C Finnes, PhD (+46 70 374 08 79, anna.finnes@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Work Ability Index (WAI) including Work Ability Score (WAS) (time frame: WAI: Baseline, 6 months, 1- and 2 year follow-up. WAS: every two weeks during the first six months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in